Health News Releases

  • Today November 13
December 22, 2016 15:25
Octapharma Presents Key Data with Nuwiq® in Previously Untreated Patients from the NuProtect Study at the American Society of Hematology (ASH) Annual Meeting in San Diego, USA
On Sunday, 4th December, 2016 Octapharma presented interim data from the ongoing phase 3 study, NuProtect at the 58th ASH Annual Meeting & Exposition in San Diego, California. The presentation was nom
December 21, 2016 11:40
Oral PDE-4 Inhibitor, OTEZLA®, Approved for the Treatment of Plaque Psoriasis and Psoriatic Arthritis in Japan
Celgene Corporation (NASDAQ:CELG) today announced that OTEZLA® (apremilast), Celgene’s oral selective inhibitor of phosphodiesterase 4 (PDE4), has been granted full marketing authorization by Japan’s
Give HUREN to your family for a Christmas gift
December 20, 2016 16:51
Give HUREN to your family for a Christmas gift!
It is expected that the product line of domestic optical lens which is well known for the advertisement phrase “Eyes know the difference” will hit this winter. HUREN (optical lens brand of Daemyung
December 20, 2016 10:25
Ferring and IMAB Sign Licensing Agreement Granting IMAB Exclusive Rights in Asia to Olamkicept for the Treatment of Autoimmune Disease
Ferring Pharmaceuticals and IMAB today announced that they have signed a licensing agreement which grants IMAB exclusive rights to olamkicept (pINN) in Asia. Olamkicept is a new recombinant protein
December 19, 2016 09:35
CHMP adopts a positive opinion acknowledging that Jardiance® reduces the risk of CV death
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) today adopted a positive opinion to update the Jardiance® (empagliflozin) label including a change to t
Dae Myung Optical Openen New Official Website (www.dmo.co.kr).
December 16, 2016 15:06
Daemyung Optical Opens New Official Website
Daemyung Optical(DMO)(www.dmo.co.kr) has reformed its website to enforce communications with clients both domestically and internationally with its 31st year anniversary . The new webpages after th
December 16, 2016 09:59
Brainlab ExacTrac Integrates Varian’s PerfectPitch to Enable Highly Accurate Radiosurgery Treatments With Advanced 6D Correctional Accuracy
Brainlab released ExacTrac® 6.2, a new version of its successful room-based patient positioning system providing full interoperability with the PerfectPitch™ six-degrees of freedom couch from Varian M
December 14, 2016 13:20
Vietnam’s City International Hospital Makes Commitment to Patient Safety Movement Foundation
The Patient Safety Movement Foundation (PSMF) announces that City International Hospital in Ho Chi Min City, Vietnam, is the newest international healthcare provider to make a commitment toward the PS
December 13, 2016 11:20
Alvogen Launches the First Generic Equivalent to Tamiflu® Capsules in the United States
Today, Alvogen has launched the first generic equivalent to Tamiflu® (oseltamivir phosphate) capsules in the United States. Alvogen expects the generic equivalent to Tamiflu® capsules to deliver signi
December 09, 2016 12:00
Provision Healthcare Receives FDA Clearance of the ProNova SC360 Proton Therapy System
Provision Healthcare’s research, development and manufacturing subsidiary, ProNova Solutions, has received FDA 510(k) clearance for its SC360 proton therapy system only four years after commencing res
December 08, 2016 19:25
ABOUND Data Presented at the World Conference on Lung Cancer Further Explores Safety and Efficacy of ABRAXANE® for Challenging Patient Populations
Celgene Corporation (NASDAQ:CELG) today announced interim results from the ABOUND clinical trial program evaluating the use of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension)
December 08, 2016 10:25
Boehringer Ingelheim HCP Survey: Nearly 20% of newly diagnosed lung cancer patients tested for EGFR mutations at risk of missing out on personalised treatments for their disease
Results from a new international survey of physicians revealed more patients with advanced non-small cell lung cancer (NSCLC) could benefit from targeted therapy based on their lung cancer type, over
December 08, 2016 10:20
Clinically meaningful data for oral nintedanib in mesothelioma presented at World Conference on Lung Cancer
Boehringer Ingelheim today announced that the LUME-Meso Phase II trial in patients with unresectable malignant pleural mesothelioma (MPM) met its primary endpoint of progression-free survival (PFS). T
December 08, 2016 09:05
New governance at CellProthera
CellProthera, which offers the most advanced cell therapy for the regeneration of the damaged heart muscle after myocardial infarction, has changed its corporate governance and appointed Matthieu de K
December 07, 2016 16:10
Ancillare Announces New Vice President of Asia-Pacific
Ancillare, LP, the leader in end-to-end global clinical trial ancillary supply chain management services for pharmaceutical, biotechnology, contract research and medical research organizations, announ
December 06, 2016 11:55
Amano Dental Clinic (Japan) Launches Tooth Brushing App “Brush‘n’Save” Created by Active Dentist to Ensure Cavity-Free Life for His Daughter
Amano Dental Clinic (Director: Kiyoshi Amano) announces that it is now offering Dr. Amano’s originally created brushing app “Brush‘n’Save” in an English version to 130 countries and regions all around
December 06, 2016 10:00
Early Data Demonstrate Clinical Activity of Acalabrutinib in Difficult-to-Treat Chronic Lymphocytic Leukaemia
AstraZeneca and its haematology Centre of Excellence, Acerta Pharma, today announced preliminary results from the Phase I/II ACE-CL-001 clinical trial of acalabrutinib in subsets of patients with two
December 05, 2016 20:20
GVK BIO Announces Launch of a GMP Compliant Analytical Services Laboratory
GVK Biosciences, one of Asia’s leading life sciences service organizations, today announced the launch of an Analytical Services Laboratory in Hyderabad, India. The dedicated GMP compliant facility is
December 05, 2016 19:10
New Data Show High Adherence Rates with Pradaxa® (dabigatran etexilate) in NVAF Patients
Boehringer Ingelheim today announced results from a new analysis of the GLORIA™-AF Registry Program, which showed that newly diagnosed non-valvular atrial fibrillation (NVAF) patients treated with Pra
December 05, 2016 16:55
Florida’s Parrish Medical Center is the First Hospital to Commit to All 12 Actionable Patient Safety Solutions (APSS)
The Patient Safety Movement Foundation (PSMF) is very proud to announce that Parrish Medical Center in Titusville, Florida, has become the first hospital to make formal commitments that align with all
December 05, 2016 14:00
Cerevance Launched with New Technology, Drug Portfolio and $36M in Cash to Tackle Brain Diseases
Takeda Pharmaceutical Company Limited (TOKYO:4502): This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161201006597/en/ · Takeda and
December 05, 2016 10:00
Takeda and Seattle Genetics Report Positive Phase 3 ALCANZA Clinical Trial Data of ADCETRIS® (Brentuximab Vedotin) for CD30-Expressing Cutaneous T-Cell Lymphoma
Takeda Pharmaceutical Company Limited (TSE:4502) and Seattle Genetics, Inc. (NASDAQ: SGEN) today announced that data from the Phase 3 ALCANZA clinical trial evaluating ADCETRIS (brentuximab vedotin) i
December 02, 2016 18:15
QuintilesIMS Named Best Full-service Provider CRO in 2016 Scrip Awards
QuintilesIMS has been recognized by the 2016 Scrip Awards as the Best Full-service Provider Contract Research Organization (CRO). This marks the sixth time in the last eight years that the company has
December 01, 2016 17:45
Cook Medical Opens New Distribution Centre in Singapore
Cook Medical officially opened its new state of the art South Asia Distribution Centre (SADC) in Singapore on 30th November 2016. The new facility is part of a rapid expansion of Cook Medical’s supply
December 01, 2016 11:50
Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos Collaborate on Nanotechnology R&D Platform
Ferring Pharmaceuticals and Aché Laboratórios Farmacêuticos today announced a long-term collaboration aimed at improving the bioavailability, efficacy and safety profile of oral therapeutic medicines
25 per page50 per page75 per page100 per page